Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BIO-TECHNE (TECH) Return on Equity: 2010-2025

Historic Return on Equity for BIO-TECHNE (TECH) over the last 15 years, with Sep 2025 value amounting to 0.01%.

  • BIO-TECHNE's Return on Equity fell 4.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of 0.01% for FY2025, which is 5.00% down from last year.
  • Latest data reveals that BIO-TECHNE reported Return on Equity of 0.01% as of Q3 2025, which was up 22.23% from 0.01% recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Return on Equity ranged from a high of 0.16% in Q3 2022 and a low of 0.01% during Q2 2025.
  • Over the past 3 years, BIO-TECHNE's median Return on Equity value was 0.06% (recorded in 2024), while the average stood at 0.07%.
  • In the last 5 years, BIO-TECHNE's Return on Equity dropped by 10bps in 2021 and then climbed by 8bps in 2022.
  • Over the past 5 years, BIO-TECHNE's Return on Equity (Quarterly) stood at 0.10% in 2021, then grew by 4bps to 0.15% in 2022, then declined by 5bps to 0.10% in 2023, then decreased by 4bps to 0.06% in 2024, then dropped by 4bps to 0.01% in 2025.
  • Its Return on Equity stands at 0.01% for Q3 2025, versus 0.01% for Q2 2025 and 0.04% for Q1 2025.